HRT and Alzheimer's Disease

Published Online: Wednesday, January 1, 2003

The bad news is that hormone replacement therapy (HRT) may increase the likelihood of breast cancer in postmenopausal women. The good news, according to the results of a study published in the Journal of the American Medical Association (November 6, 2002), is that women who have taken HRT for at least 10 years are 2.5 times less likely to develop Alzheimer?s disease than non-HRT women.

The following are 2 other key points from this study: First, there was no benefit unless HRT had been begun several years before the onset of mental decline. Second, vitamin and calcium supplements had no effect on Alzheimer?s disease risk.



Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues
$auto_registration$
VSEO N/A